Yan-Ting Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

End Stage Renal Disease

Ejection Fraction

Top Venues

British journal of haematology

International journal of hematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yan-Ting Liu, Yu-Han Gao, Hao Zhao, Miao-Yan Zhang, Ming-Hui Duan, Jian Li, Lu Zhang
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study. Annals of hematology (2024)
Lu Zhang, Yu-Han Gao, Si-Yuan Li, Hao Zhao, Miao-Yan Zhang, Yan-Ying Yu, Yan-Ting Liu, Jian Li
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease. International journal of hematology (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology 204 (5) (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology 204 (5) (2024)
Lu Zhang, Yu-Han Gao, Si-Yuan Li, Hao Zhao, Miao-Yan Zhang, Yan-Ying Yu, Yan-Ting Liu, Jian Li
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease. International journal of hematology 119 (6) (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology (2024)